VIRBAC DANMARK A/S: Financial statements 2012
CVR: 16313637
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
VIRBAC DANMARK A/S (CVR 16313637) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 30,298,744 and a net result of DKK 5,133,569. Equity in the 2012 report amounted to DKK 12,764,893. The solvency ratio was 60.8%. The company had 13 employees in the financial year.
- Gross Profit
- DKK 30,298,744
- Profit/Loss
- DKK 5,133,569
- Equity
- DKK 12,764,893
- Total Assets
- DKK 20,980,564
- Employees
- 13
Official annual report
Keep an eye on VIRBAC DANMARK A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout VIRBAC DANMARK A/S
VIRBAC DANMARK A/S is a Danish company of the type Aktieselskab based in Kolding, founded in 1992. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PHARMALETT A/S and A/S PSE 38 NR. 1583. The management consists of Betina Ebdrup. The board consists of Enguerrand Dubois (chair), Charlotte Honor Covell and Peter Sejerkilde. The company is owned by Virbac SA. The company has 18 employees (2018). In 2025, the company reported a gross profit of DKK 59,336,583 and a net result of DKK -861,159 compared with DKK 7,280,398 the year before. Equity in the 2025 report amounted to DKK 18,787,510.